tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

MedPlus Subsidiary Faces Temporary Drug License Suspension

Story Highlights
MedPlus Subsidiary Faces Temporary Drug License Suspension

Claim 70% Off TipRanks Premium

The latest announcement is out from MedPlus Health Services Ltd. ( (IN:MEDPLUS) ).

MedPlus Health Services Ltd. announced that its subsidiary, Optival Health Solutions Private Limited, has received a two-day suspension order for a drug license at a store in Telangana. This suspension, issued by the Drugs Control Administration, is expected to result in a potential revenue loss of approximately Rs 0.87 lacs, highlighting a minor operational setback for the company.

More about MedPlus Health Services Ltd.

MedPlus Health Services Ltd. operates in the healthcare industry, primarily focusing on providing pharmaceutical products and health services. The company is based in Hyderabad, India, and is known for its extensive network of retail pharmacy stores across the country.

Average Trading Volume: 21,491

Technical Sentiment Signal: Strong Buy

Current Market Cap: 97.07B INR

For a thorough assessment of MEDPLUS stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1